All In Biotech

Free tool

FAERS Monitor: Pretomanid

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 212862 or its brand name (Pretomanid, Pretomanid). Reports on generic versions are filed under their own applications.

Reports

760

Serious

739

97% of reports

Hospitalization

166

Death reported

294

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • death126
  • anaemia84
  • neuropathy peripheral81
  • off label use68
  • nausea57
  • electrocardiogram qt prolonged53
  • decreased appetite28
  • acute kidney injury27
  • toxicity to various agents26
  • alanine aminotransferase increased23
  • aspartate aminotransferase increased22
  • hepatotoxicity22
  • vomiting22
  • asthenia20
  • thrombocytopenia17

Reports by year received

View as table
YearReports
20152
20163
20184
201913
20209
20214
202269
2023126
2024173
2025192
2026165

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,053,399 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
electrocardiogram qt prolongedSignal5340.831.52,021
hepatotoxicitySignal2227.418.1533
neuropathy peripheralSignal8123.619.21,736
anaemiaSignal8412.210.0859
aspartate aminotransferase increasedSignal2211.57.6200
alanine aminotransferase increasedSignal2310.46.9186
acute kidney injurySignal274.93.480
toxicity to various agentsSignal264.32.962
thrombocytopeniaSignal174.22.639
deathSignal1264.03.5298
decreased appetiteSignal283.32.344
off label useSignal682.11.742
nausea572.01.628
asthenia201.51.03
vomiting221.30.91

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.